BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1263 related articles for article (PubMed ID: 16907843)

  • 21. Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantation.
    McMillan JS; Bowden DS; Angus PW; McCaughan GW; Locarnini SA
    Hepatology; 1996 Dec; 24(6):1371-8. PubMed ID: 8938164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
    Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients.
    Huang YH; Wu JC; Chang TT; Sheen IJ; Huo TI; Lee PC; Su CW; Lee SD
    J Viral Hepat; 2006 May; 13(5):336-42. PubMed ID: 16637865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study.
    Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
    J Infect Dis; 2006 Sep; 194(5):594-9. PubMed ID: 16897657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma.
    Jang JW; Chun JY; Park YM; Shin SK; Yoo W; Kim SO; Hong SP
    Cancer Sci; 2012 Feb; 103(2):296-304. PubMed ID: 22136288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
    Khan A; Kurbanov F; Tanaka Y; Elkady A; Sugiyama M; Dustov A; Mizokami M
    J Med Virol; 2008 Feb; 80(2):268-76. PubMed ID: 18098133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study.
    Yin J; Zhang H; He Y; Xie J; Liu S; Chang W; Tan X; Gu C; Lu W; Wang H; Bi S; Cui F; Liang X; Schaefer S; Cao G
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):777-86. PubMed ID: 20160279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mutation of hepatitis B virus DNA pre-C region in patients with primary hepatocellular carcinoma in Guangxi].
    Fang Z; He B; Zhuang H; Ring L; Harrison TJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Mar; 34(2):83-5. PubMed ID: 11860905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study.
    Chen CH; Changchien CS; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN
    J Infect Dis; 2008 Dec; 198(11):1634-42. PubMed ID: 18939932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
    Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
    Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
    Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
    Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Low frequency of precore stop mutation in patients with dual infection of hepatitis B and C viruses].
    Qiu W; Hou J; Lou K
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):133-5. PubMed ID: 12515190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis.
    Teramoto T; Satonaka K; Kitazawa S; Fujimori T; Hayashi K; Maeda S
    Cancer Res; 1994 Jan; 54(1):231-5. PubMed ID: 8261444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of full length sequences of hepatitis B virus isolates in hepatocellular carcinoma patients and asymptomatic carriers of Korea.
    Song BC; Kim H; Kim SH; Cha CY; Kook YH; Kim BJ
    J Med Virol; 2005 Jan; 75(1):13-9. PubMed ID: 15543574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B, and delta viruses.
    Oyunsuren T; Kurbanov F; Tanaka Y; Elkady A; Sanduijav R; Khajidsuren O; Dagvadorj B; Mizokami M
    J Med Virol; 2006 Dec; 78(12):1688-95. PubMed ID: 17063518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients.
    Raimondo G; Brunetto MR; Pontisso P; Smedile A; Maina AM; Saitta C; Squadrito G; Tono N;
    Hepatology; 2006 Jan; 43(1):100-7. PubMed ID: 16323213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM
    J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.